Anti-KMT2D / MLL2 antibody
0
(1 Review)
|
(7 Publications)
Rabbit Polyclonal KMT2D / MLL2 antibody. Suitable for IHC-P, ICC/IF and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Recombinant Fragment Protein within Human KMT2D aa 4350-4500.
View Alternative Names
ALR, MLL2, MLL4, KMT2D, Histone-lysine N-methyltransferase 2D, Lysine N-methyltransferase 2D, ALL1-related protein, Myeloid/lymphoid or mixed-lineage leukemia protein 2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-KMT2D / MLL2 antibody (AB224156)
PFA-fixed, Triton X-100 permeabilized A431 (human epidermoid carcinoma cell line) cells stained for KMT2D / MLL2 (green) using ab224156 at 4 μg/ml in ICC/IF.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KMT2D / MLL2 antibody (AB224156)
Paraffin-embedded human cerebral cortex tissue stained for KMT2D / MLL2 using ab224156 at 1/200 dilution in immunohistochemical analysis.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KMT2D is an important regulatory factor that influences gene expression. It is part of a larger complex that includes other interacting proteins necessary for histone modification. Through its enzymatic activity KMT2D impacts gene transcription by modifying chromatin structure making it more or less accessible for transcription factors to bind DNA. This control over gene expression has implications in development differentiation and cellular response to external stimuli.
Pathways
KMT2D integrates into the broader framework of chromatin modification and transcriptional regulation pathways. It interacts with proteins such as ASH2L and RBBP5 which are components of the COMPASS-like complex playing roles in modifying histones to regulate gene expression dynamically. KMT2D's function intersects particularly with the Hedgehog and Wnt signaling pathways both important for developmental processes and cellular proliferation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Molecular pain 21:17448069251314857 PubMed39905828
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 14:e1753 PubMed38967349
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 10: PubMed36289705
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 28:76 PubMed35768768
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of personalized medicine 11: PubMed34834500
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:669560 PubMed33968779
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & phar 115:108924 PubMed31100540
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com